BRIEF published on 11/20/2024 at 18:43, 19 hours ago Fuller, Smith & Turner PLC Executes Share Buyback Voting Rights Share Buyback Treasury Shares Numis Securities Fuller’s
PRESS RELEASE published on 11/20/2024 at 18:38, 19 hours 5 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 2,500 'A' ordinary shares at an average price of 694.0000 GBp each, as part of its share buyback programme Voting Rights London Stock Exchange Share Buyback Numis Securities Limited Fuller Smith Turner PLC
BRIEF published on 11/19/2024 at 18:10, 1 day 19 hours ago Fuller, Smith & Turner PLC Engages in Share Buyback London Stock Exchange Ordinary Shares Share Buyback Treasury Shares Fuller, Smith & Turner
PRESS RELEASE published on 11/19/2024 at 18:05, 1 day 19 hours ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of 'A' ordinary shares as part of share buyback program on the London Stock Exchange through Numis Securities Limited London Stock Exchange Share Buyback Numis Securities Limited FSTA Fuller Smith Turner
BRIEF published on 11/18/2024 at 18:59, 2 days 18 hours ago Fuller, Smith & Turner PLC Executes Share Buyback Voting Rights London Stock Exchange Share Buyback Treasury Shares Fuller, Smith & Turner
PRESS RELEASE published on 11/18/2024 at 18:54, 2 days 18 hours ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC purchases 10,056 'A' ordinary shares of 40p each on the London Stock Exchange as part of its buyback program London Stock Exchange Shares Fuller, Smith & Turner PLC Purchase Buyback Program
BRIEF published on 11/15/2024 at 17:58, 5 days 19 hours ago Fuller, Smith & Turner PLC Executes Share Buyback Ordinary Shares Share Buyback Numis Securities Market Regulation Fuller’s
PRESS RELEASE published on 11/15/2024 at 17:53, 5 days 19 hours ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of share buyback program, holding repurchased shares in Treasury London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Numis Securities Limited Own Shares
BRIEF published on 11/14/2024 at 19:05, 6 days 18 hours ago Fuller, Smith & Turner PLC Share Buyback Update Voting Rights Share Buyback Treasury Shares Stock Exchange Fuller, Smith & Turner
PRESS RELEASE published on 11/14/2024 at 19:00, 6 days 18 hours ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchasing 14,095 of its own 'A' ordinary shares as part of the share buyback program on 14/11/2024 London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Numis Securities Limited Own Shares
Published on 11/21/2024 at 13:30, 14 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 14 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 44 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 44 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 44 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 9 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 29 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 46 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 24 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 59 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 59 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
